{
    "2021-06-20": [
        [
            {
                "time": "",
                "original_text": "证监会严查药明康德股东上海瀛翊违规减持套现29亿 上海瀛翊办公地址不详 第一大LP为泰康保险集团 金融监管处罚",
                "features": {
                    "keywords": [
                        "证监会",
                        "药明康德",
                        "上海瀛翊",
                        "违规减持",
                        "套现",
                        "金融监管"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北上资金净流出超50亿，终止连续9周抢筹，医药龙头遭甩卖，融资客却趁机抄底",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净流出",
                        "医药龙头",
                        "甩卖",
                        "抄底"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "摊上事了！顶级药械企业违规减持29亿，或面临数十亿索赔！ 减持股份数量",
                "features": {
                    "keywords": [
                        "顶级药械企业",
                        "违规减持",
                        "索赔",
                        "减持股份数量"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "证券市场禁入新规下月实施 药明康德股东违规减持立案调查 减持股份数量",
                "features": {
                    "keywords": [
                        "证券市场禁入新规",
                        "药明康德",
                        "违规减持",
                        "立案调查"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}